A previous study indicated that ROR2 might serve as an independent prognostic factor for squamous/adenosquamous carcinoma and gallbladder adenocarcinoma patients, and that ROR2 suppression might inhibit squamous carcinoma and gallbladder adenocarcinoma growth [13]. This evidence concerns the gene ROR2 and gallbladder adenocarcinoma.